HCT Core Topics Connection Module: Conditioning Regimens Used in Hematopoietic Cell Transplantation


Back to Package

This module will identify the goals of administering a conditioning regimen prior to HCT, discuss the non-hematologic dose limiting toxicities of chemotherapy agents commonly utilized in conditioning regimens, differentiate between myeloablative, reduced-intensity, and non-myeloablative conditioning regimens, and select an appropriate conditioning regimen for a patient based on disease and patient specific factors.

Presented by:

Binni Kunvarjee, PharmD, BCOP; Memorial Sloan Kettering Cancer Center

Maggie Nelson, PharmD, BCOP; The University of Kansas Health System

Vinita Pai, PharmD, MS; The Ohio State University and Nationwide Children’s Hospital


Key:

Complete
Failed
Available
Locked
Module Recording
Open to view video.
Open to view video.
Slides
Open to download resource.
Open to download resource.
Module Quiz
10 Questions  |  4 attempts  |  8/10 points to pass
10 Questions  |  4 attempts  |  8/10 points to pass
Evaluation
6 Questions
Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available